Fulgent Genetics (FLGT) Current Leases (2019 - 2026)

Fulgent Genetics has reported Current Leases for 8 years, with the latest figure at $1.9 million in Q2 2026.

• Quarterly Current Leases rose 56.28% year-over-year to $1.9 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $1.9 million (up 56.28% YoY) and the FY2025 annual result came in at $1.5 million, up 1.32% from the prior year.
• Current Leases retreated to $1.9 million in Q2 2026 per FLGT's latest filing, from $1.9 million in the prior quarter.
• Over five years, Current Leases peaked at $6.1 million in Q4 2022 and troughed at $1.2 million in Q2 2025.
• A 5-year average of $2.3 million and a median of $1.7 million in 2025 frame the typical range for Current Leases.
• The sharpest annual moves came in 2024 and 2026: Current Leases slumped 63.53% in 2024, then soared 56.28% in 2026.
• Over 5 years, Current Leases stood at $6.1 million in 2022, then plunged by 35.47% to $4.0 million in 2023, then plunged by 63.53% to $1.4 million in 2024, then gained by 1.32% to $1.5 million in 2025, then advanced by 26.88% to $1.9 million in 2026.
• According to Business Quant data, Current Leases over the past three periods registered $1.9 million, $1.9 million, and $1.5 million for Q2 2026, Q1 2026, and Q4 2025 respectively.